Back to Search Start Over

Review: Dapagliflozin increases, and empagliflozin reduces, adverse renal events in type 2 diabetes.

Authors :
Nguyen JT
Molony DA
Source :
Annals of internal medicine [Ann Intern Med] 2017 Jul 18; Vol. 167 (2), pp. JC5.
Publication Year :
2017

Subjects

Subjects :
Benzhydryl Compounds
Humans
Hypoglycemic Agents
Diabetes Mellitus, Type 2
Glucosides

Details

Language :
English
ISSN :
1539-3704
Volume :
167
Issue :
2
Database :
MEDLINE
Journal :
Annals of internal medicine
Publication Type :
Academic Journal
Accession number :
28715827
Full Text :
https://doi.org/10.7326/ACPJC-2017-167-2-005
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details